Papewalis, C <br/><br/>
Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer.  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  Oct 2009 
 - 752-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1439-4286 
<br/><br/><label>Standard No.: </label>10.1055/s-0029-1224116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Everolimus<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Proliferating Cell Nuclear Antigen--genetics<br/>Protein Kinases--genetics<br/>RNA--chemistry<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases<br/>Thyroid Neoplasms--drug therapy